FAGR Fagron SA

Alychlo has successfully completed a private sale of shares in Fagron

Alychlo has successfully completed a private sale of shares in Fagron

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES (INCLUDING ITS TERRITORIES AND POSSESSIONS, ANY STATE OF THE UNITED STATES OR THE DISTRICT OF COLUMBIA), AUSTRALIA, CANADA, JAPAN, SOUTH AFRICA OR ANY OTHER JURISDICTION IN WHICH SUCH RELEASE, PUBLICATION OR DISTRIBUTION WOULD BE UNLAWFUL.

Regulated information

Nazareth (Belgium)/Rotterdam (The Netherlands), 5 June 2020

Alychlo has successfully completed a private sale of shares in Fagron

Fagron NV (“Fagron”) has been informed by Alychlo NV (“Alychlo”) of the private sale of 3,000,000 existing ordinary shares of Fagron (the “Shares”). This represents c. 4.2% of Fagron’s current outstanding share capital. The Shares have been sold today to several institutional investors. Following the private sale, Alychlo holds just over 10% of Fagron’s current outstanding share capital.

Marc Coucke, Chairman of Alychlo: “This sale allows for a further diversification of Alychlo’s assets while remaining a fully committed shareholder of Fagron.”

Joh. Berenberg, Gossler & Co. KG acted as Bookrunner in connection with the private sale.

In the event of differences between the English translation and the Dutch original of this press release, the latter prevails.

For more information

Constantijn van Rietschoten

Chief Communications Officer

Tel. 85

Please open the link below for the press release:

EN
05/06/2020

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Fagron SA

Robert Jan Vos ... (+2)
  • Robert Jan Vos
  • Usama Tariq
 PRESS RELEASE

Fagron publishes its Annual Report 2025

Fagron publishes its Annual Report 2025 Regulated informationNazareth (Belgium)/Rotterdam (The Netherlands), 6 March 2026 7AM CET Fagron publishes its Annual Report 2025 Fagron, the leading global player in pharmaceutical compounding, today publishes its Annual Report 2025, further to its earlier announcement of Fagron's annual financial results for the financial year 2025 on February 12, 2026. The Annual Report is available on Fagron's in both Dutch (official version, including the ESEF-tagged version) and English. It comprises the annual financial report relating to the consolidated f...

 PRESS RELEASE

Fagron publiceert haar Jaarverslag 2025

Fagron publiceert haar Jaarverslag 2025 Gereglementeerde informatieNazareth (België)/Rotterdam (Nederland), 6 maart 2026 – 7:00 CET Fagron publiceert haar Jaarverslag 2025 Fagron, de toonaangevende wereldwijde speler in farmaceutische bereidingen, publiceert vandaag haar Jaarverslag 2025, volgend op de eerdere bekendmaking van Fagron's jaarlijkse financiële resultaten over het boekjaar 2025 op 12 februari 2026.  Het Jaarverslag is beschikbaar op de van Fagron in zowel het Nederlands (officiële versie, inclusief ESEF-getagde versie) als in het Engels. Het Jaarverslag omvat het financieel...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch